Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Clasificación en acciones #509
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Precio por acción
$7.88
Última sincronización: 2026-08-12
Capitalización bursátil
$50.25B
Cambio (1 día)
-1.11%
Cambio (1 año)
-9.73%
País
CN
Comercio Jiangsu Hengrui Medicine Co., Ltd. (600276)

Categoría

Historial del precio de la acción de Jiangsu Hengrui Medicine Co., Ltd. (600276)
Precio más alto de cierre: $7.90 el 2026-08-01

Precio más bajo de cierre: $0.04 el 2005-07-01
Historial del precio de la acción de Jiangsu Hengrui Medicine Co., Ltd. desde 2005 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -3.56%
2025 33.70%
2024 2.96%
2023 15.17%
2022 -30.24%
2021 -37.82%
2020 50.21%
2019 73.88%
2018 25.89%
2017 85.51%
2016 3.95%
2015 100.95%
2014 12.39%
2013 42.52%
2012 4.92%
2011 -16.03%
2010 40.18%
2009 61.62%
2008 -8.70%
2007 153.91%
2006 239.46%
2005 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$166.06 27.73%
DE
$36.20 22.35%
JP
$228.90 41.12%
CH
$21.45 14.41%
IN